FDA Grants Full Approval To Oral Nirmatrelvir/Ritonavir For Adults At High Risk Of Severe COVID-19

The AP (5/25, Perrone) reports that the FDA granted full approval on Thursday to Pfizer’s pill Paxlovid (nirmatrelvir/ritonavir) “for adults with COVID-19 who face high risks of severe disease, which can lead to hospitalization or death.” Reuters (5/25, M...